This article is more than 5 years old. Information may no longer be current.
Medicrea receives FDA approval for reportedly first patient-specific cervical rod
Click Here to Manage Email Alerts
Medicrea announced it has received FDA approval for the reportedly first patient-specific UNiD cervical rod for spine surgery, secured with the company’s PASS OCT posterior cervical stabilization system, according to a company press release.
After receiving FDA clearance, Medicrea expanded its UNiD technology and services for the cervical spine with the first implantation of the patient-specific cervical rod. The company also announced that UNiD lab personalized spinal alignment services are available to cover the cervical, thoracic and lumbar regions.
“The patient-specific cervical rod option is a natural extension of the UNiD portfolio,” Denys Sournac, president and chief executive officer, said in the release. “By providing patient-specific realignment implant options for the entire spine, we are again confirming Medicrea’s leadership position in personalized, made-to-measure treatments. This continued expertise brings pioneering technologies and services to the spine that are uniquely dedicated to improving clinical results for each patient.”
The cervical rod is custom-designed to match the shape of the rod with the patient’s spinal alignment and the surgeon’s preoperative plan. According to the release, the UNiD cervical rod removes surgical barriers by creating two identical single- or dual-diameter rods designed specifically for the patient and sent directly to the OR.
Reference: